After completing a comprehensive review, Cboe is realigning its portfolio of businesses to sharpen its strategic focus on core strengths and emerging growth opportunities. This includes: Initiating a sales process for Cboe Australia and Cboe Canada; Discontinuing U.S. and European Corporate Listings efforts; Reducing costs related to U.S. and European ETP Listings businesses, Cboe Europe Derivatives, and several of Cboe’s smaller Risk and Market Analytics businesses. “This strategic realignment of our business portfolio and human capital ensures Cboe is well positioned to succeed in a dynamic and evolving market and supports our long-term vision to be a global derivatives leader. With strong momentum, as demonstrated from our results this year, and a clear direction, we’re confident in our ability to drive transformative growth and long-term value for shareholders,” said Craig Donohue, Cboe Global Markets (CBOE) CEO.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBOE:
- Cboe Global Markets reports Q3 adjusted EPS $2.85, consensus $2.53
- Cboe Global Markets sees FY25 revenue up in the low double-digit to mid-teens
- Cboe Global Markets (CBOE) Q3 Earnings Cheat Sheet
- Cboe Global Markets price target lowered to $260 from $261 at BofA
- Cboe Global Markets price target raised to $270 from $265 at Piper Sandler